Chimeric Therapeutics Limited (ASX:CHM)
Australia · Delayed Price · Currency is AUD 0.0030
+0.0010 (50.00%)
Sep 5, 2025, 4:10 PM AEST
Chimeric Therapeutics Market Cap
Chimeric Therapeutics has a market cap or net worth of 9.76 million as of September 5, 2025. Its market cap has decreased by -41.34% in one year.
Market Cap
9.76M
Enterprise Value
4.01M
Revenue
12.68M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.00
Market Cap Chart
Since January 18, 2021, Chimeric Therapeutics's market cap has decreased from 97.50M to 9.76M, a decrease of -89.99%. That is a compound annual growth rate of -39.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2025 | 6.51M | -40.96% |
| Dec 31, 2024 | 11.02M | -56.60% |
| Dec 29, 2023 | 25.40M | -27.35% |
| Dec 30, 2022 | 34.97M | -59.93% |
| Dec 31, 2021 | 87.26M | -10.51% |
| Jan 18, 2021 | 97.50M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 100.05B |
| Pro Medicus | 30.39B |
| Cochlear | 19.36B |
| Sonic Healthcare | 11.24B |
| Ramsay Health Care | 7.78B |
| Ansell | 4.99B |
| Telix Pharmaceuticals | 4.79B |
| Mesoblast | 2.48B |